Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Scandinavian Biopharma Holding AB

Closing information (x1000 DKK)

Closing information 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Turnover 104,532 Less Arrow 103,694 Less Arrow 81,384
Financial expenses 21 Less Arrow 11 More Arrow 339
Earnings before taxes 628 Less Arrow 461 Less Arrow 152
EBITDA 347 Less Arrow -242 More Arrow 863
Total assets 74,690 More Arrow 83,609 Less Arrow 80,398
Current assets 72,447 More Arrow 81,537 Less Arrow 79,089
Current liabilities 65,975 More Arrow 75,633 Less Arrow 70,308
Equity capital 8,715 Less Arrow 7,975 More Arrow 10,090
- share capital 164 More Arrow 170 Less Arrow 169
Employees (average) 35 Less Arrow 30 Less Arrow 27

Financial ratios

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Solvency 11.7% Less Arrow 9.5% More Arrow 12.6%
Turnover per employee 2,987 More Arrow 3,456 Less Arrow 3,014
Profit as a percentage of turnover 0.6% Less Arrow 0.4% Less Arrow 0.2%
Return on assets (ROA) 0.9% Less Arrow 0.6% Equal arrow 0.6%
Current ratio 109.8% Less Arrow 107.8% More Arrow 112.5%
Return on equity (ROE) 7.2% Less Arrow 5.8% Less Arrow 1.5%
Change turnover 4,268 More Arrow 21,891 Less Arrow 18,703
Change turnover % 4% More Arrow 27% More Arrow 30%
Chg. No. of employees 5 Less Arrow 3 Less Arrow 2
Chg. No. of employees % 17% Less Arrow 11% Less Arrow 8%

Total value of public sale

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.